Stephen M. Kelsey

Phase I Clinical Study of Pertuzumab, a Novel HER Dimerization Inhibitor, in Patients With Advanced Cancer

David B. Agus, Michael S. Gordon, Charles Taylor et al. · Journal of Clinical Oncology · 2005 · 388 citations · Full text

Medicine, Oncology, Pharmacology +7

An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients.

A O’Farrell, James M. Foran, Walter Fiedler et al. · PubMed · 2003 · 311 citations

Medicine, Pharmacokinetics, Pharmacology +17

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes

David Bowen, Dominic Culligan, Simon N. Jowitt et al. · British Journal of Haematology · 2003 · 297 citations

Medicine, Hematology, Internal Medicine +15

Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Sharmila Makhija, Lukas C. Amler, D. Glenn et al. · Journal of Clinical Oncology · 2009 · 187 citations

Medicine, Oncology, Pharmacology +17

Phase I Study of GRN1005 in Recurrent Malignant Glioma

Jan Drappatz, Andrew Brenner, Eric T. Wong et al. · Clinical Cancer Research · 2013 · 181 citations

Medicine, Oncology, Pharmacology +17